Clinical Trial

Testing Experimental Treatment for Advanced Solid Tumors

Study Description

A Study of LY3435151 in Participants With Solid Tumors

The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - LY3435151

Administered IV

Drug - Pembrolizumab

Administered IV

Additional Information

Official Study Title

A Phase 1a/1b Study of LY3435151 Administered to Patients With Advanced Solid Tumors

Clinical Trial ID

NCT04099277

ParticipAid ID

azpkYd